Cancer Immunotherapy At A Crossroads
(By Bret Stetka for NPR) It was in 1909 that Nobel Prize-winning German physician Paul Ehrlich proposed the idea that
Read More
Part D/Prescription Drugs
HHS Issues New Rules To Open Up Data From Clinical Trials
(By Richard Harris for NPR) Universities and drug companies that use human volunteers for research face tough new rules designed
Read MoreColombia plans to proceed with price cut on Novartis cancer drug
(By Ed Silverman for ST A T) After weeks of deliberations, the Colombia health minister is proceeding with plans to
Read MoreFDA chastises companies for touting an unapproved opioid painkiller
(By Ed Silverman for ST A T) F ile this under “What were they thinking?” At a time when selling
Read MoreDoes access to medical marijuana reduce opioid deaths?
(By Sharon Begley for ST A T) W hen legal medical marijuana dispensaries start operating in a state, deaths from
Read MoreLawmakers ask HHS to probe the Medicaid drug rebate program
(By Ed Silverman for ST A T) I n the wake of the controversy over EpiPen pricing, 1 a group
Read MoreCandidates Decry High Drug Prices, But They Have Few Options For Voters
(By Julie Rovner for Kaiser Health News) In this year’s presidential campaign, health care has taken a back seat. But
Read MoreWATCH: How EpiPens — and epinephrine — stop a serious allergic reaction
(By Ike Swetlitz for ST A T) E piPens. They can quickly deliver a lifesaving dose of the chemical epinephrine
Read MoreBipartisan bill in Congress would require drug makers to justify, limit price hikes
(By Ed Silverman for ST A T) I n response to the intensifying outrage over the cost of medicines, a
Read MoreFDA panel votes to remove serious warning from Pfizer’s smoking cessation pill
(By Ed Silverman for ST A T) P fizer won a crucial battle in its quest to widen the market
Read More